Need Help? Chat Now With a Live Representative!

Atlantic Research Group To Sponsor ENCALS In Barcelona 12-14 July

Atlantic Research Group To Sponsor ENCALS In Barcelona 12-14 July

Atlantic Research Group To Sponsor ENCALS In Barcelona 12-14 July

June 16, 2023

Atlantic Research Group will be acting as a sponsor for the ENCALS (European Network to Cure ALS) meeting in Barcelona, Spain from 12 to 14 July, 2023. ENCALS, the network of ALS Centres in Europe, has a stated goal: “The ultimate aim of our collaboration is to cure ALS." ARG, proud sponsor of the conference, is firmly committed to the neurodegenerative diseases community.

At ARG, we recognize that we need to continually grow our knowledge of neurodegenerative conditions as we concurrently evolve in our experience. The neurodegenerative community, especially in ALS,  is a tight-knit group, and we are fortunate to be a part of it. By staying in the know, interfacing with Investigators, and participating in conferences, we keep up with the trends that drive the trials that will ultimately help patients.

Our repeated success over time in neurodegenerative studies is rooted in our long-term commitment to knowledge, relationships, patients, and treatments. Neurodegenerative diseases such as ALS are very challenging for patients in clinical trials. As a result, it is imperative that the study teams have experience in and understanding of ALS in order to foster patient centricity. All of the stakeholders must be taken into account in order to create a stable project environment.

Ignazio Di Giovanna, PhD, VP, Scientific Affairs, Neurology and Faisal Zaman, Director, Project Operations, will be attending ENCALS. Please visit our contact page to arrange a discussion.

The Vital Role of Team Stability in Advancing Clinical Trials

The Vital Role of Team Stability in Advancing Clinical Trials

In the fast-paced world of clinical research, turnover rates are high and project continuity can be a challenge. However, at […]

March 29, 2024
Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
GO TO TOP